Victory Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $782K | Buy |
|
|||||
|
2025
Q2 | $109K | Buy |
|
|||||
|
2025
Q1 | $48.5K | Sell |
|
|||||
|
2024
Q4 | $48.8K | Buy |
|
|||||
|
2024
Q3 | $33.5K | Buy |
|
|||||
|
2024
Q2 | $25.3K | Buy |
|
|||||
|
2024
Q1 | $39.9K | Sell |
|
|||||
|
2023
Q4 | $27.9K | Sell |
|
|||||
|
2023
Q3 | $861K | Buy |
|
|||||
|
2023
Q2 | $606K | Buy |
|
|||||
|
2023
Q1 | $144K | Buy |
|
|||||
|
2022
Q4 | $11.4K | Sell |
|
|||||
|
2022
Q3 | $6K | Sell |
|
|||||
|
2022
Q2 | $8K | Buy |
|
|||||
|
2022
Q1 | $10K | Sell |
|
|||||
|
2021
Q4 | $53K | Sell |
|
|||||
|
2021
Q3 | $70K | Buy |
|
|||||
|
2021
Q2 | $89K | Buy |
|
|||||
|
2021
Q1 | $78K | Buy |
|
|||||
|
2020
Q4 | $63K | Buy |
|
|||||
|
2020
Q3 | $53K | Sell |
|
|||||
|
2020
Q2 | $303K | Sell |
|
|||||
|
2020
Q1 | $288K | Buy |
|
|||||
|
2019
Q4 | $190K | Buy |
|
|||||
|
2019
Q3 | $78K | Buy |
|